For the National Bowel Cancer Screening Program (NBCSP), participation refers to the proportion of people invited who returned a completed screening test during a specified period.
Participation in the NBCSP is measured over 2 calendar years to align with the 2-year recommended screening interval. Participation rates are calculated using an additional 6 months of data after the end of the 2-year invitation period, to allow time for all invitees to complete and return their screening kit. Participation rates in this section are preliminary and these rates are presented to one decimal place in this release.
These data are sourced from live databases that are updated over time and may differ from other AIHW cancer screening reports where the data are sourced at a different time.
Explore the latest data in the visualisation below.
According to the 2020–2021 preliminary data:
- Almost 6.1 million people aged 50–74 were invited to participate in the NBCSP.
- Almost 2.5 million people returned a completed bowel screening test.
- The national participation rate was 40.9%.
Participation by sex and age
According to the 2020–2021 preliminary data:
- Women had a higher participation rate than men (42.8% compared with 38.9%).
- Those aged 70–74 years had the highest participation rate (52.1%).
- Those aged 50–54 years had the lowest participation rate (31.6%).
Between 2014–2015 and 2020–2021:
- The national participation rate has increased from 38.9% of invited people aged 50–74 in 2014–2015 to 43.8% in 2019–2020.
- The participation rate has dropped from 43.5% in 2018–2019 to 40.9% in 2020–2021. It is still unclear why this drop has occurred.
Since 2018 the program has widened its target ages resulting in a steady increase in the number of invitees over time (See the National Bowel Cancer Screening Program age groups invited by year section of the Technical notes for more information).
According to the 2020–2021 preliminary data:
- Both South Australia and Tasmania had the highest bowel screening participation rates for people aged 50–74 (44.4%).